Tags

Type your tag names separated by a space and hit enter

The role of RAS modification for primary and secondary stroke prevention.
Postgrad Med. 2009 Jul; 121(4):115-22.PM

Abstract

Clinical trial results indicate that the choice of antihypertensive agent can be a determinant of stroke protection, independent of blood pressure (BP) reduction. Angiotensin-converting enzyme inhibitors (ACE-Is) are effective for BP control and stroke protection, but their use may be limited by patient tolerability. Angiotensin receptor blockers appear to provide similar BP control compared with ACE-Is and may also offer the clinician the added benefit of primary and secondary stroke prevention, with the potential for fewer tolerability issues.

Authors+Show Affiliations

Division of Cardiology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA. dfintel@northwestern.edu

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

19641277

Citation

Fintel, Dan J.. "The Role of RAS Modification for Primary and Secondary Stroke Prevention." Postgraduate Medicine, vol. 121, no. 4, 2009, pp. 115-22.
Fintel DJ. The role of RAS modification for primary and secondary stroke prevention. Postgrad Med. 2009;121(4):115-22.
Fintel, D. J. (2009). The role of RAS modification for primary and secondary stroke prevention. Postgraduate Medicine, 121(4), 115-22. https://doi.org/10.3810/pgm.2009.07.2037
Fintel DJ. The Role of RAS Modification for Primary and Secondary Stroke Prevention. Postgrad Med. 2009;121(4):115-22. PubMed PMID: 19641277.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The role of RAS modification for primary and secondary stroke prevention. A1 - Fintel,Dan J, PY - 2009/7/31/entrez PY - 2009/7/31/pubmed PY - 2009/8/21/medline SP - 115 EP - 22 JF - Postgraduate medicine JO - Postgrad Med VL - 121 IS - 4 N2 - Clinical trial results indicate that the choice of antihypertensive agent can be a determinant of stroke protection, independent of blood pressure (BP) reduction. Angiotensin-converting enzyme inhibitors (ACE-Is) are effective for BP control and stroke protection, but their use may be limited by patient tolerability. Angiotensin receptor blockers appear to provide similar BP control compared with ACE-Is and may also offer the clinician the added benefit of primary and secondary stroke prevention, with the potential for fewer tolerability issues. SN - 1941-9260 UR - https://www.unboundmedicine.com/medline/citation/19641277/The_role_of_RAS_modification_for_primary_and_secondary_stroke_prevention_ L2 - http://www.tandfonline.com/doi/full/10.3810/pgm.2009.07.2037 DB - PRIME DP - Unbound Medicine ER -